Study On the Expression Level and Clinical Significance of VISTA in Patients With Vascular Cognitive Impairment

RecruitingOBSERVATIONAL
Enrollment

400

Participants

Timeline

Start Date

March 1, 2023

Primary Completion Date

November 30, 2028

Study Completion Date

November 30, 2028

Conditions
Cerebrovascular Disease Small Vessel
Interventions
DIAGNOSTIC_TEST

Neuropsychological testing

The primary outcomes were Mini-Mental State Examination and Montreal Cognitive Assessment scores for screening of cognitive decline, which are recommended by NINDS-AIREN. The secondary outcomes included the performance in five cognition domains: (1) verbal memory, Hopkins Verbal Learning Test ; (2) visual-spatial ability, Clock Drawing test; (3) executive function, Trail Making test (TMT) (B time); (4) attention, TMT (A time); and (5) language tests, Boston Naming test2 (BNT-2)

Trial Locations (1)

150010

RECRUITING

First Affiliated Hospital of Harbin Medical University, Harbin

All Listed Sponsors
lead

First Affiliated Hospital of Harbin Medical University

OTHER